1 / 20

ANPS Anatomy & Physiology

This article explores the various types of stress and their impact on the body's homeostasis. It discusses the activation of the sympathetic nervous system, the hypothalamic-pituitary-adrenal axis, and the release of cortisol. Additionally, it delves into the actions of glucocorticoids and their therapeutic uses and potential side effects.

gainesn
Télécharger la présentation

ANPS Anatomy & Physiology

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. ANPS Anatomy & Physiology Endocrinology III

  2. Stress - anything that perturbs homeostasis Bad Emotional – exams, bills, bad job Physical – drugs, hard labor, wound Metabolic – starvation, cold, heat Combination – car accident, combat, rape Good Exercise Nervous system activation Sympathetic stimulation - adrenal chromaffin release of epinephrine (E) β1 receptor - heart; increase rate and pulse pressure β2 - vasodilation in muscles (more blood to do work) - fiber release of norepinephrine (NE) α1 – vasoconstriction in peripheral tissues and gut Endocrine system activation Hypothalamic-pituitary-adrenal (HPA) axis stimulation – cortisol release - redistribution of fuel - enhances sympathetic E function - activates genes for stress adaptation

  3. ACTH and Hypothalamic- Pituitary-Adrenal (HPA) Axis Responses • Stress, pain, circadian drive activate • hypothalamic CRH release • CRH binds GPCRs on anterior • pituitary corticotroph cells • Corticotrophs release ACTH • ACTH binds to adrenal cortical • GPCRs for cortisol release • Cortisol binds to steroid receptors • Cortisol has long feedback to • hypothalamus and pituitary gland

  4. ACTH -endorphin Pro-opiomelanocortin (POMC) Precursor to adrenocorticotropin (ACTH) and -endorphin Anterior pituitary Hypothalamus brain (anorexic peptide suppresses appetite)

  5. Aldosterone Cortisol Androgens Epinephrine (adrenalin) Adrenal gland • cortex – 3 contiguous layers • medulla – sympathetic • -chromaffin cells (E) Adrenal glands

  6. Cholesterol ACTH zona glomerulosa zona fasciculata zona reticularis Cortisol Corticosterone Aldosterone Androgen Glucocorticoids

  7. Cortisol • cortisol is lipophilic and enters cells • cortisol binds to cytosolic glucocorticoid (steroid) receptors (GR) • associated with chaperone heat-shock protein (HSP90) • bound GR complex translocates into nucleus • complex acts as transcription factor to activate • or repress genes on a variety of tissues (-) cortisol glucocorticoid receptor (GR) (+)

  8. Cortisol actions: • metabolic • vascular • anti-inflammatory/immunosuppressive • Metabolic: • “gluco” in glucocorticoids implies increased • blood glucose levels • liver – stimulates gluconeogenesis • fat – stimulates lipolysis, inhibits • glucose uptake • muscle – stimulates protein catabolism; • amino acids for gluconeogenesis, • inhibits glucose uptake • net effect – diabetogenic (important in fasting) • Vascular: • enhances epinephrine function to • maintain vascular tone and pressure

  9. Anti-inflammatory / immunosuppressive: • **cortisol inhibits inflammatory mediators • (prostaglandins, interleukins, thromboxane, • TNF, etc) • reduces T lymphocytes / interferon production* • decreases antibody production (long term)* • * important in transplants to inhibit rejection But ... in excess (chronic stress or medication): centripetal (trunk) obesity muscle wasting and thin skin from connective tissue loss – poor wound healing increased infections from immune suppression bone resorption/loss – osteoporosis sodium retention and potassium loss from binding to mineralocorticoid receptors

  10. Glucocorticoids: the good vs bad in therapeutics • The good: • the anti-inflammatory/immunosuppressive effects • of glucocorticoids (hydrocortisone, dexamethasone) • are used therapeutically to blunt severe inflammation, • allergic reactions, autoimmune responses and • transplant rejections • The bad: • long term use can lead to immunosuppression • (bad for infections), muscle wasting, • osteoporosis, hyperglycemia, obesity, • neural/psychiatric disorders

  11. Pancreas, Islets and Glucose Homeostasis • Insulin is the key regulator of blood glucose • Insulin actions are opposed and balanced by glucagon • β-islet cells – insulin (green) • α-islet cells – glucagon (red) exocrine/endocrine pancreas endocrine Islets of Langerhans

  12. , brain Glucose transporters (GLUT): the other key players

  13. Triggering insulin release • increase in blood glucose (after a meal) result in glucose entry into β-cells via GLUT2 • cellular glucose metabolism result in increased ATP • increase in ATP inhibits intracellular K+ efflux (KATP channels) • increase in cellular K+ results in cell depolarization and calcium entry • increased calcium stimulates insulin release from secretory granules Islet β-cells depolarization

  14. Islet β-cell insulin production • synthesized as 84 amino acid chain • 3 disulfide bonds • intervening connecting peptide (also called C-peptide) • is removed by dibasic RR/KR cleavage

  15. Insulin-receptor signaling • insulin binds to tyrosine receptor kinase in muscle, fat and other tissues • different signaling pathways from scaffold increase • cell survival/proliferation, decrease glucose synthesis, • and increase GLUT4 transporter insertion to enhance cell glucose entry α insulin receptor dimerization glucose entry β P P IRS Shc Sos Grb2 P P PI3K Ras Raf increase GLUT4 translocation into membrane (muscle/fat) P P P P MEK Akt P P ERK increase cell survival/proliferation decrease gluconeogenesis

  16. GLUT2 GLUT4 Triglycerides (fat storage) (muscle / liver storage)

  17. Elevated glucose levels will: • increase insulin-depdendent GLUT4 insertion into tissues for glucose entry • increase tissue glycogen production and storage • (from excess glucose) in liver and muscle • increase fatty acid/triglyceride synthesis/storage in fat • increase amino acid into tissues for protein synthesis • inhibit glycogen breakdown (inhibits glycogenolysis) • inhibit new glucose synthesis (inhibits gluconeogenesis) • inhibit lipolysis and reduce circulating free fatty acids • net result is glycogen and triglyceride storage (i.e., fuel storage)

  18. From decreased in blood glucose levels (between meals, fasting): • glucagon is released from islet α-cells • glucagon binds to target tissue G protein-coupled receptors • receptor activation of cAMP/PKA pathways result • in enzyme phosphorylation and activity • Glucagon effects are (opposite to insulin): • increased glycogenolysis (breakdown • of glycogen) to release glucose • increased gluconeogenesis in liver • increased lipolysis to free fatty acids • and keto acids • increased protein breakdown to amino acids • net effect is fuel mobilization to serve • metabolic demands

  19. Diabetes – 2 types Type I diabetes mellitus (juvenile onset diabetes) About 5% of all cases Genetic predisposition – autoimmune disease attacking beta cells Pancreatic beta cells fail Environmental factors Type II diabetes mellitus (adult onset diabetes) About 95% of all cases Genetic predisposition (many genes from genome studies) Body responds poorly to insulin (tissue insulin resistance likely because of fat) Eventual pancreatic beta cell “burn-out” - can’t keep up Biggest culprit: overeating / obesity

More Related